Regulatory Affairs: SOP for Country-Specific Registration Requirement Review – V 1.0

Standard Operating Procedure for Country-Specific Registration Requirement Review

Department	Regulatory Affairs
SOP No.	RA/2026/653
Supersedes	NA
Page No.	1 of X
Issue Date	10/04/2026
Effective Date	10/04/2026
Review Date	10/04/2028

Purpose

This Standard Operating Procedure (SOP) outlines the systematic approach for reviewing country-specific registration requirements to ensure all product registrations comply with the regulatory standards and guidelines of individual countries. The objective of this SOP is to control and standardize the review process, thereby minimizing regulatory risks and facilitating timely and successful market approval and entry.

Scope

This SOP applies to all products, including pharmaceuticals, biologics, and medical devices, managed by the Regulatory Affairs department for market registration in different countries. It covers the identification, collection, review, and interpretation of country-specific regulatory requirements related to dossiers, labeling, packaging, submission timelines, and compliance documentation. The SOP excludes internal manufacturing validations, quality control analyses, and post-market surveillance activities.

Responsibilities

Regulatory Affairs Executives: Perform initial collection and compilation of country-specific registration requirements.
Regulatory Affairs Specialists: Conduct detailed review, interpretation, and comparison of regulatory documents against internal standards.
Regulatory Affairs Manager: Supervise the review process, ensure compliance, and approve final review reports.
Quality Assurance: Verify adherence to applicable quality systems and support compliance audits related to registration requirements.
Documentation Control: Manage SOP and related documentation revisions and archiving.

Accountability

The Regulatory Affairs Manager holds accountability for implementing this SOP, ensuring compliance with relevant regulatory standards, conducting periodic reviews, escalating critical non-compliances to Senior Management, and assessing the effectiveness of the procedure during scheduled audits and continuous improvement initiatives.

Procedure

1. Preparation and Prerequisites: Obtain the latest country-specific regulatory guidance documents from recognised regulatory authority portals or appropriate official sources. Ensure access to current product dossiers and internal submission tracking systems.

2. Requirement Collection: Systematically collect information related to registration dossiers, labeling, packaging, stability data, clinical and non-clinical requirements, fees, timelines, and mandatory certifications specific to each target country.

3. Document Review and Gap Analysis: Conduct a comprehensive review of collected requirements against company-standard dossier content, internal procedures, and previous submission experiences. Identify gaps, conflicts, or additional requirements.

4. Risk and Impact Assessment: Evaluate how identified gaps may affect submission timelines, regulatory approval likelihood, or product labeling compliance. Determine corrective actions or additional data needs.

5. Internal Coordination: Communicate findings and recommendations with cross-functional teams such as Quality Assurance, Manufacturing, Clinical, and Legal departments to ensure a collaborative approach to compliance.

6. Documentation and Reporting: Prepare the country-specific registration requirement review report summarizing identified requirements, discrepancies, risk assessments, and actions to be taken. Submit the report for management review and approval.

7. Record Keeping: Store all reviewed requirement documents, reports, and communications in designated regulatory documentation control systems ensuring traceability and version control.

8. Updates and Revisions: Monitor regulatory changes in target countries continuously. Update the review report and disseminate changes promptly to all stakeholders.

9. Deviation Management: Any deviations or discrepancies found during the review should be documented and reported following internal deviation procedures. Implement corrective and preventive actions as required.

10. Training and Awareness: Ensure all relevant personnel are trained on this SOP and changes in country-specific requirements to maintain compliance and audit readiness.

This procedure provides a controlled, documented, and repeatable process for reviewing country-specific registration requirements, supporting regulatory compliance and facilitating efficient product market access.

Abbreviations

RA: Regulatory Affairs
SOP: Standard Operating Procedure
GMP: Good Manufacturing Practices
QA: Quality Assurance
CTD: Common Technical Document
EMA: European Medicines Agency
FDA: Food and Drug Administration

Documents

Country-Specific Registration Requirement Review Report (Annexure-1)
Regulatory Requirement Gap Analysis Checklist (Annexure-2)
Change Log for Regulatory Updates (Annexure-3)

References

ICH Q7 Good Manufacturing Practice Guide
FDA Guidance for Industry – Electronic Submissions
EMA Guideline on the Requirements for Quality Documentation
Local and international regulatory authority websites and regulatory frameworks
Corporate Quality Management System documentation

Version

1.0

Approval

Prepared By
Checked By
Approved By

Annexures

Annexure-1: Country-Specific Registration Requirement Review Report

Title	Country-Specific Registration Requirement Review Report
Purpose	To summarize and document the detailed review of registration requirements for a specific country to facilitate compliance and timely submission.
Fields	Country Name Product Name Registration Type Date of Review Reviewed By Summary of Requirements Identified Gaps Risk Assessment Recommended Actions Approval Status Remarks
Dummy Data	Country Name: Brazil Product Name: Product X Registration Type: New Drug Application Date of Review: 15/03/2026 Reviewed By: Regulatory Affairs Specialist Summary of Requirements: Complete CTD dossier, local labeling in Portuguese, GMP Certificate required Identified Gaps: Missing regional stability data Risk Assessment: Medium – may delay approval by 2 months Recommended Actions: Initiate stability studies for the region Approval Status: Pending Manager Review Remarks: Follow up required with Quality for stability protocols

Annexure-2: Regulatory Requirement Gap Analysis Checklist

Title

Regulatory Requirement Gap Analysis Checklist

Purpose

To provide a structured format for identifying and documenting gaps between country-specific regulatory requirements and current submission documents.

Fields

Checklist Item
Requirement Description
Compliance Status (Yes/No)
Details of Non-Compliance
Corrective Action Required
Responsible Person
Completion Date
Remarks

Dummy Data

Checklist Item	Description	Compliance	Non-Compliance Details	Corrective Action	Responsible	Completion Date	Remarks
1	Local Language Labeling	No	Label in English only	Translate and print labels as per local language	Regulatory Affairs Executive	30/04/2026	Critical requirement
2	Stability Data	No	Missing data for tropical climate	Start new stability studies	Quality Assurance	31/05/2026	Review after study completion

Annexure-3: Change Log for Regulatory Updates